Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Regulatory News (VRP)

  • There is currently no data for VRP

Verona Pharma

23 Oct 2020 17:30

RNS Number : 0995D
FTSE Russell
23 October 2020
 

 

 

 

 

Verona Pharma (UK): Constituent DeletionChanges in FTSE UK Index Series

23 October 2020

Subject to the expected cancellation of trading on AIM for Verona Pharma (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

30 October 2020

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSXXLFLBBLEFBK
Date   Source Headline
4th Oct 201312:06 pmPRNPlacing of shares
30th Sep 20137:00 amPRNHalf-yearly Report
23rd Sep 20137:00 amPRNNotice of Results
10th Sep 20137:00 amPRNClinical data presented at ERS
5th Sep 20137:01 amPRNPresentations at ERS
5th Sep 20137:00 amPRNAppointment of Richard Bungay as CFO
29th Jul 201310:13 amPRNGrant of Options
25th Jul 20131:23 pmPRNDirector Shareholding
24th Jul 20135:58 pmPRNHolding(s) in Company
23rd Jul 201312:45 pmPRNDirector Shareholding
24th Jun 20137:00 amPRNFirst patient dosed in clinical trial for VRP700
3rd Jun 20134:46 pmPRNResult of AGM
21st May 20134:00 pmPRNATS Tuesday Presentation
20th May 20137:00 amPRNATS Sunday Poster Presentations
16th May 20137:00 amPRNPresentations at ATS Conference
9th May 20138:05 amPRNPosting of Annual Report and AGM Notice
29th Apr 20137:00 amPRNNew Clinical and Scientific Advisory Board Announced
26th Apr 201310:17 amPRNDirector/PDMR Shareholding
15th Apr 20133:01 pmPRNGrant of Options
10th Apr 20133:07 pmPRNDirector's Dealing
10th Apr 201310:23 amPRNDirector Dealings
10th Apr 20137:00 amPRNFinal Results
19th Mar 20131:56 pmPRNHolding(s) in Company
5th Mar 20137:00 amPRNRPL554 demonstrates airway anti-inflammatory activity
28th Feb 20137:00 amPRNTotal Voting Rights
21st Feb 20132:35 pmPRNHolding(s) in Company
18th Feb 20132:53 pmPRNResult of General Meeting
31st Jan 201310:54 amPRNPlacing and Equity Finance Facility
24th Jan 20132:09 pmPRNNotice of Interest
18th Jan 201310:18 amPRNHolding(s) in Company
4th Jan 20132:59 pmPRNStatement Regarding Share Price Movement
12th Nov 201211:38 amPRNNotice of Interest
15th Oct 20122:01 pmPRNDirector Shareholding
12th Oct 20129:00 amPRNRPL554 Phase I/IIa data presented at ISAF 2012
26th Sep 20129:00 amPRNInvestor Presentation
17th Sep 201210:44 amPRNNew Option Scheme and Grant of Options
14th Sep 20127:00 amPRNHalf-yearly Report
6th Sep 20127:00 amPRNNotice of Interim Results
4th Sep 20127:30 amPRNVerona Pharma: RPL554 COPD Data Presented at ERS
3rd Sep 20129:30 amPRNNotice of Interest
28th Aug 20127:00 amPRNUS Patent Granted for Verona Pharma's RPL554
9th Jul 20127:00 amPRNVerona Pharma Investigates Anti-inflammatory - RPL554
1st Jun 20126:14 pmPRNResult of AGM
1st Jun 201211:30 amPRNCEO's Statement to Annual General Meeting
8th May 20124:56 pmPRNPosting of Annual Report
1st May 20127:00 amPRNVerona Pharma appoints new CEO
5th Apr 20127:00 amPRNVerona Pharma - Preliminary Unaudited Results
9th Mar 20127:00 amPRNVerona Pharma â€" First UK RPL554 anti-inflammatory trial
31st Jan 20127:00 amPRNTotal Voting Rights
16th Jan 201212:19 pmPRNNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.